Histidine-improved cancer immunosurveillance

Immunizing small cell lung cancer mice with isoaspartylated Elavl4 after chemotherapy mimics improved survival of anti-ELAVL4 antibody-positive small cell lung cancer patients
D. A. Velarde, J. A. Valdes, H. Lee +10
bioRxiv31 Aug 2026PreprintAll rights reservedFull textOncologybioRxiv
Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
D. Bukovec, M. Gjorgjievska, S. Kocevska +5
medRxiv15 Sep 2026PreprintAll rights reservedFull textOncologymedRxiv
L-Histidine alleviates tacrolimus-induced islet dysfunction via the gut-pancreas axis
Zhen Geng, Qiang Li, Duo Wang +5
iScience9 Oct 2026Peer-reviewedCC BY 4.0Full textEndocrinology & metabolismCell PressCrossrefEurope PMC
L-histidine metabolic reprogramming is associated with imipenem-relebactam resistance in carbapenem-resistant hypervirulent Klebsiella pneumoniae
Jun Li, Haolan Wang, Yuyao Wang +6
Scientific Reports28 Oct 2026Peer-reviewedCC BY-NC-ND 4.0General medicineCrossref
Decoding the Sequence Determinants of DNA Cleavage in Histidine-Containing Copper(II) Metallopeptides
Ana B. Caballero, Olga Iranzo, Patrick Gamez
ChemRxiv6 Oct 2026PreprintCC BY-NC-NDFull textOncologyChemRxiv

Cite

BibTeX

@article{fidelle2026histidineimproved,
  title = {{Histidine-improved cancer immunosurveillance}},
  author = {Marine Fidelle and Ella Reich and Laurence Zitvogel and Guido Kroemer},
  journal = {OncoImmunology},
  year = {2026},
  month = aug,
  doi = {10.1080/2162402x.2026.2713805},
  url = {https://hal.science/hal-05738746v1},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Histidine-improved cancer immunosurveillance
AU  - Marine Fidelle
AU  - Ella Reich
AU  - Laurence Zitvogel
AU  - Guido Kroemer
PY  - 2026
DA  - 2026/08/13
JO  - OncoImmunology
DO  - 10.1080/2162402x.2026.2713805
UR  - https://hal.science/hal-05738746v1
SN  - 2162-4011
SN  - 2162-402X
ER  -

Related

Cite